Logo

NCI Awards Insightful $186K to Develop Cancer Prevention Research Software

Feb 07, 2006

NEW YORK, Feb. 7 (GenomeWeb News) - The National Cancer Institute has awarded Insightful two contracts worth a total of $185,807 to develop advanced bioinformatics software to analyze and evaluate proteomic cellular signatures in cancer prevention research, Insightful said today.

 

The software will use Insightful's S-Plus 7 and S+ArrayAnalyzer products, the company said.

 

The initial contracts call for solutions to the "challenges of preprocessing mass spectrometry data," Insightful said. The company is planning to develop software that includes calibration, denoising, baseline detrending, intensity normalization, peak detection, alignment, feature selection and extraction, as well as graphics.

 

Insightful said the funding will be recorded in the company's financial statements as a reduction to research and development expense.

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.